Healthcare News

This Weight Loss Pill Could Increase Your Cancer Risk

Written by David Miller

As per a recent release, the drug lorcaserin (Belviq, Belviq XR) has reportedly been withdrawn by its manufacturing pharmaceutical company Eisai after a warning from the FDA stated that there's a possibility that the drug could increase a person’s risk of cancer.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]